دورية أكاديمية
Beyond Dual Bronchodilation - Triple Therapy, When and Why
| العنوان: | Beyond Dual Bronchodilation - Triple Therapy, When and Why |
|---|---|
| المؤلفون: | Cazzola, Mario, Rogliani, Paola, Laitano, Rossella, Calzetta, Luigino, Matera, Maria Gabriella |
| المساهمون: | Cazzola, M, Rogliani, P, Laitano, R, Calzetta, L, Matera, Mg |
| سنة النشر: | 2022 |
| المجموعة: | Universitá degli Studi di Roma "Tor Vergata": ART - Archivio Istituzionale della Ricerca |
| مصطلحات موضوعية: | ICSs, LABs, LAMAs, dual bronchodilation, triple therapy, Settore MED/10 - MALATTIE DELL'APPARATO RESPIRATORIO |
| الوصف: | Although pharmacological treatment of COPD is codified in different guidelines and strategy documents, there is abundant evidence of discrepancy between what they suggest and what health professionals prescribe, especially in low-risk groups where there is widespread overprescription of triple therapy. It is therefore necessary to clarify when the use of triple therapy is indicated in COPD patients and when it is preferable to maintain treatment with dual bronchodilation. In this article, we discuss our views based on our experience and what is reported in the literature and try to give answers to these two questions. The evidence generated by pivotal RCTs supports the use of triple therapy in patients who present for the first time and have severe airway obstruction, are symptomatic, have had frequent moderate or severe exacerbations in the previous year, and have peripheral eosinophilia. However, it is difficult to determine whether step-up is useful in all other cases because the available data are quite conflicting. It is likely that the inconsistency in the information generated by the various available studies may explain the prescribing behaviour of many physicians who do not adhere to recommendations of guidelines and strategies. However, it is necessary to establish whether and when the addition of an ICS to the LAMA/LABA combination is effective, to determine whether triple therapy can induce an additional clinical benefit over dual bronchodilation, irrespective of a preventive effect on COPD exacerbations, to establish its value, and to examine whether cost differences can support the use of triple therapy over combined LAMA/LABA therapy in real life. |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| العلاقة: | info:eu-repo/semantics/altIdentifier/pmid/35068929; info:eu-repo/semantics/altIdentifier/wos/WOS:000783194500003; volume:17; firstpage:165; lastpage:180; numberofpages:16; journal:INTERNATIONAL JOURNAL OF COPD; https://hdl.handle.net/2108/330823Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85123744260 |
| DOI: | 10.2147/COPD.S345263 |
| الإتاحة: | https://doi.org/10.2147/COPD.S345263Test https://hdl.handle.net/2108/330823Test |
| حقوق: | info:eu-repo/semantics/openAccess |
| رقم الانضمام: | edsbas.9D272B4A |
| قاعدة البيانات: | BASE |
| DOI: | 10.2147/COPD.S345263 |
|---|